Doctors Make Big Money Testing Urine For Drugs, Then Ignore Abnormal Results
Medicare and insurers struggle to oversee a booming business in testing urine samples. In some cases, pain doctors’ lack of follow-through can turn fatal.
Drugs
1,061 - 1,080 of 1,298 Results
-
-
Heated And Deep-Pocketed Battle Erupts Over 340B Drug Discount Program
Drugmakers, hospitals and lawmakers are taking sides in a showdown over a discount program that covers drug purchases at some hospitals.
-
Podcast: ‘What The Health?’ Meanwhile, In Other Health News…
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Alice Ollstein of Talking Points Memo and Sarah Jane Tribble of Kaiser Health News discuss some of the under-covered health stories of the past several weeks, including drug price issues, the opioid epidemic and women’s reproductive health.
-
Years Before Heading Offshore, Herpes Researcher Experimented On People In U.S.
Southern Illinois University’s William Halford conducted unregulated human herpes experiments in hotels near university campus, emails show.
-
Doctor’s Rx For A Stiff Knee: A Prescription For 90 Percocet Pills
Following minor surgery, KHN’s consumer columnist sees how easily doctors offer pain pills, fueling epidemic of opioid addiction.
-
Massachusetts Grabs Spotlight By Proposing New Twist On Medicaid Drug Coverage
In an effort to reduce drug costs and increase efficiency, Massachusetts is seeking federal approval to implement a new approach to how the state’s Medicaid program covers prescription medications.
-
FDA Raids Florida Stores That Consumers Use To Buy Drugs From Canada
The federal agents warned store owners that importing drugs from foreign countries is illegal and that those helping “administer” such medicines could face penalties.
-
Medicare Seeks Comment On Ways To Cut Costs Of Part D Drugs
Medicare is examining how rebates and discounts could be shared in some way with Part D beneficiaries to reduce their out-of-pocket costs.
-
Pressure Builds To Cut Medicare Patients In On Prescription Deals
Medicare officials have been discussing a rule change that would give beneficiaries a share of the secretive fees and discounts that are negotiated for prescription drugs.
-
Study Gives Mixed Reviews On Laws To Equalize Cancer Patients’ Out-Of-Pocket Costs
Most states have laws that require that cancer patients who get their treatment orally rather than by infusion in a doctor’s office not pay more out-of-pocket. A new study finds that the impact of those laws is mixed.
-
Ohio’s Drug-Pricing Ballot Question Triggers Voter Confusion
Millions of dollars in campaign spending and a media blitz of advertisements muddy public understanding of Issue 2, the Drug Price Relief Act.
-
Liquid Gold: Pain Doctors Soak Up Profits By Screening Urine For Drugs
With the nation's opioid crisis, urine testing has become a booming business and is especially lucrative for doctors who operate their own labs, a Kaiser Health News investigation finds. And dozens of practitioners have earned "the lion’s share" of their Medicare income exclusively from urine drug screens.
By Fred Schulte and Elizabeth Lucas -
Health Companies Race To Catch UnitedHealth As Amazon Laces Up
UnitedHealth, a health industry goliath, has its hand in doctors’ offices, surgery centers, technology services and prescription drugs. It is the industry model, and CVS and Aetna, says one expert, are ‘wannabes.’
By Chad Terhune -
House Republicans Aim To Yank Tax Credits For Orphan Drugs
House Republicans want to repeal federal tax credits that have helped spur a boom in orphan drugs for rare diseases.
-
Timeline: Insulin Market Under Scrutiny
A flurry of federal and state probes have targeted insulin manufacturers and pharmacy benefit managers — middlemen in the prescription drug-pricing pipeline. Here, we connect the legal dots.
-
Flurry Of Federal And State Probes Target Insulin Drugmakers And Pharma Middlemen
Over the past two years, a powerful federal prosecutor and several state attorneys general have launched investigations related to diabetes drugs.
-
Desperate Quest For Herpes Cure Launched ‘Rogue’ Trial
Patients flocked to researcher who ignored usual patient protections, as university claimed ignorance.
-
Cascade of Costs Could Push New Gene Therapy Above $1 Million Per Patient
The costs of using a new class of cancer treatments include far more than the drug’s sticker price.
By Liz Szabo -
New Law Challenges ‘Evils’ Of Pharma Profits, California Governor Claims
Gov. Jerry Brown signed the measure, which takes effect next year and will require drug companies to publicly justify big price increases.
-
Eyes Fixed On California As Governor Ponders Inking Drug Price Transparency Bill
"If it gets signed by this governor, it's going to send shock waves throughout the country,” one legislator says. Pharma has spent $16.8 million lobbying against this bill and other drug laws in California.